Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Bliss GVS Pharma Ltd - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the shareholder. This is for your information and records.
31-05-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for transmission of shares cum issuance of duplicate share certificates. This is for your information and record.
30-05-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report29/05/2019 3 Name of the Certifying Firm Ramesh Chandra Mishra & Associates 4 Name of the Certifying Individual Ramesh Chandra Mishra 5Membership TypeFCS 6 Membership Number 5477 7 CP No. 3987 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO
30-05-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 This is to inform you that pursuant to the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the Board of Directors of the Company has approved and adopted amended 'Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information'. This amended Code shall be effective from April 01, 2019. The revised Code as attached is also available at the website of the Company at www.blissgvs.com. Kindly take the above information on your record and acknowledge.
23-05-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for transmission of shares cum issuance of duplicate share certificates.
21-05-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Enclosed herewith investor presentation on Company's performance for the quarter and year ended March 31, 2019. Kindly take the same on record.
21-05-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of audited financial results of the Company for the quarter and year ended March 31, 2019 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on May 21, 2019. Kindly take the same on record.
21-05-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Fixes Book Closure for Dividend & AGM

 Bliss GVS Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 14, 2019 to September 20, 2019 (both days inclusive) for the purpose of Payment of Dividend & 33rd Annual General Meeting (AGM) of the Company to be held on September 20, 2019.
21-05-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Polus Global Fund
20-05-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Outcome of Board Meeting

 With reference to the Outcome of Board Meeting submitted to your stock exchanges on Saturday, May 18, 2019, we wish to inform you that in point no. 3 & 4 of the said outcome, we have made a minor typographical errors with regard to face value of the Company which was wrongly mentioned as Rs. 10/- and holding year of Annual General Meeting of the Company which was erroneously mentioned as 33rd Annual General Meeting. The Corrected sentence is:- 3. Recommended a dividend of Re. 1/- per equity share of face value of Re. 1/- each for the financial year ended March 31, 2019, subject to approval of the shareholders in the ensuing Annual General Meeting (AGM) of the Company. 4. The 34th Annual General Meeting of the Members of the Company will be held on Friday, September 20, 2019 at the Hotel Mirador, New Link Road, Andheri (East), Mumbai-400 099. Kindly take the above information on your record and acknowledge.
20-05-2019
Next Page
Close

Let's Open Free Demat Account